공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

여행용 백신 시장 : 세계 업계 동향, 점유율, 규모, 성장, 기회, 예측(2021-2026년)

Travel Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

리서치사 IMARC Services Private Limited
발행일 2021년 04월 상품 코드 999836
페이지 정보 영문 107 Pages
가격
US $ 1,999 ₩ 2,293,000 PDF (Single User License)
US $ 2,499 ₩ 2,867,000 PDF (5 User License)
US $ 2,999 ₩ 3,441,000 PDF (Corporate License)


여행용 백신 시장 : 세계 업계 동향, 점유율, 규모, 성장, 기회, 예측(2021-2026년) Travel Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
발행일 : 2021년 04월 페이지 정보 : 영문 107 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 여행용 백신 시장 규모는 2020년에 29억 4,000만 달러에 달했습니다. 여행 예방접종이라고도 불리는 여행용 백신은 여행자가 세계의 특정 지역을 방문하기 전에 입수할 수 있는 백신이며, 심각한 질병으로부터 몸을 지키는데 도움이 됩니다. 여행용 백신은 미생물 또는 그것이 방어하는 질병 미생물의 일부에 신체를 노출시킴으로써 작용합니다. 신체는 백신 접종에 반응하고, 향후 질병에 노출되는 상황으로부터 신체를 보호하는 항체를 만듭니다.

세계의 국제 관광객 도착수는 2012년 10억명에서 2018년에는 약 14억명으로 증가했습니다. 이러한 여행자의 상당한 수가 선진국으로부터 풍토병이 있는 지역으로 여행하고 있습니다. 더 많은 사람들이 풍토병이 있는 국가로 여행함에 따라 백신 수요는 계속 증가할 것입니다. 또한 세계의 규제 당국은 여행자가 질병에 걸리기 쉬운 지역으로 여행하기 전에 예방접종을 받는 것을 의무화하고 있습니다. 그 결과 여행용 백신은 현재 국제 여행자 리스트의 필수 요건이 되고 있습니다. 예를 들어 사우디아라비아 왕국 보건성은 황열병, 수막염균성 수막염, 폴리오 등의 질병 위험이 있는 국가 또는 지역에서 메카 순례와 움라를 위해 도착하는 모든 여행자에게 유효한 예방접종 증명서를 제시하도록 의무화하고 있습니다. 여행용 백신 수요를 촉진하는 또 다른 요인으로는 의식 레벨 향상, 기술 진보, 생명을 위협하는 감염증 발생률 상승 등이 있습니다. 세계의 여행용 백신 시장은 2021-2026년간 8.10%의 CAGR로 확대될 것으로 예측됩니다.

세계의 여행용 백신(Travel Vaccines) 시장에 대해 조사했으며, 시장 개요와 함께 조성별, 질환별, 지역별 동향 및 시장에 참여하는 기업 개요 등을 제공합니다.

목차

제1장 서문

제2장 범위와 조사 방법

제3장 주요 요약

제4장 서론

제5장 세계의 여행용 백신 시장

  • 시장 개요
  • 시장 실적
  • COVID-19의 영향
  • 조성별 시장 세분화
  • 질환별 시장 세분화
  • 지역별 시장 세분화

제6장 시장 세분화, 조성별

  • 모노 백신
  • 혼합 왁신

제7장 시장 세분화, 질환별

  • A형 간염
  • DPT
  • 황열병
  • 장티푸스
  • B형 간염
  • 홍역과 볼거리
  • 광견병
  • 수막염균
  • 수두
  • 일본뇌염
  • 기타

제8장 시장 세분화, 지역별

  • 북미
  • 유럽
  • 아시아태평양
  • 중동과 아프리카
  • 라틴아메리카

제9장 세계의 여행용 백신 업계 : SWOT 분석

  • 개요
  • 강점
  • 약점
  • 시장 기회
  • 위협

제10장 세계의 여행용 백신 업계 : 밸류체인 분석

  • 탐색 단계
  • 전임상 및 임상 개발
  • 규제 당국 승인
  • 제조
  • 마케팅과 유통

제11장 세계의 여행용 백신 업계 : Porter's Five Forces 분석

  • 개요
  • 구매자의 협상력
  • 공급 기업의 협상력
  • 경쟁
  • 신규 참여업체의 위협
  • 대체품의 위협

제12장 세계의 여행용 백신 업계 : 가격 분석

제13장 여행용 백신 제조 공정

  • 제품 개요
  • 원재료 요건
  • 제조 공정
  • 주요 성공요인과 위험요인

제14장 경쟁 상황

  • 시장 구조
  • 주요 기업
  • 주요 기업 개요
    • GlaxoSmithKline Pharmaceuticals Limited
    • Sanofi Pasteur
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer Inc.
    • ALK-Abello A/S
    • Bavarian Nordic A/S
    • Crucell(Subsidiary of Johnson & Johnson)
    • CSL Limited
    • AstraZeneca PLC
    • Altimmune, Inc.
    • Abbott Laboratories
    • Hoffmann-La Roche, Inc.
KSM 21.04.23

List of Figures

  • Figure 1: Global: Travel Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Travel Vaccines Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Travel Vaccines Market: Breakup by Composition (in %), 2020
  • Figure 4: Global: Travel Vaccines Market: Breakup by Disease (in %), 2020
  • Figure 5: Global: Travel Vaccines Market: Breakup by Region (in %), 2020
  • Figure 6: Global: Travel Vaccines Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 7: Global: Travel Vaccines Industry: SWOT Analysis
  • Figure 8: Global: Travel Vaccines Industry: Value Chain Analysis
  • Figure 9: Global: Travel Vaccines Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Travel Vaccines (Mono Vaccines) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 11: Global: Travel Vaccines (Mono Vaccines) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 12: Global: Travel Vaccines (Combination Vaccines) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 13: Global: Travel Vaccines (Combination Vaccines) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 14: Global: Travel Vaccines (Hepatitis A) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 15: Global: Travel Vaccines (Hepatitis A) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: Travel Vaccines (DPT) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: Travel Vaccines (DPT) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: Travel Vaccines (Yellow Fever) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: Travel Vaccines (Yellow Fever) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 20: Global: Travel Vaccines (Typhoid) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 21: Global: Travel Vaccines (Typhoid) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 22: Global: Travel Vaccines (Hepatitis B) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: Travel Vaccines (Hepatitis B) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: Travel Vaccines (Measles and Mumps) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: Travel Vaccines (Measles and Mumps) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: Global: Travel Vaccines (Rabies) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Global: Travel Vaccines (Rabies) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: Global: Travel Vaccines (Meningococcal) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 29: Global: Travel Vaccines (Meningococcal) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 30: Global: Travel Vaccines (Varicella) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: Global: Travel Vaccines (Varicella) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 32: Global: Travel Vaccines (Japanese Encephalitis) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 33: Global: Travel Vaccines (Japanese Encephalitis) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 34: Global: Travel Vaccines (Others) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 35: Global: Travel Vaccines (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 36: North America: Travel Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 37: North America: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 38: Europe: Travel Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 39: Europe: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: Asia Pacific: Travel Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: Asia Pacific: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: Middle East and Africa: Travel Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: Middle East and Africa: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: Latin America: Travel Vaccines Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: Latin America: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: Travel Vaccines Manufacturing: Process Flow

List of Tables

  • Table 1: Global: Travel Vaccines Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Travel Vaccines Market Forecast: Breakup by Composition (in Million US$), 2021-2026
  • Table 3: Global: Travel Vaccines Market Forecast: Breakup by Disease (in Million US$), 2021-2026
  • Table 4: Global: Travel Vaccines Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 5: Travel Vaccines: Raw Material Requirements
  • Table 6: Global: Travel Vaccines Market Structure
  • Table 7: Global: Travel Vaccines Market: Key Players

The global travel vaccines market reached a value of US$ 2.94 Billion in 2020. Travel vaccines, also known as travel immunizations, are vaccines travelers can get before they visit certain regions across the globe which help protect them from serious diseases. Travel vaccines work by exposing the body to a microorganism or parts of the microorganism of the disease it will protect against. The body responds to the vaccination by making antibodies that will protect it against a situation where there is an exposure to the disease in the future.

The number of international tourist arrivals worldwide increased from 1.0 Billion in 2012 to nearly 1.4 Billion in 2018. A significant number of these travelers journey from developed countries to regions with endemic diseases. As more people travel to countries with endemic diseases, the demand for vaccines will continue to increase. Moreover, regulatory authorities across the globe have also mandated that travelers should be vaccinated before traveling to disease-prone regions. As a result, travel vaccines have now become an essential requirement in an international travelers list. For instance, the Ministry of Health in the Kingdom of Saudi Arabia requires that all travelers arriving for Hajj and Umrah from countries or areas at risk of diseases such as yellow fever, Meningococcal meningitis and Poliomyelitis must present a valid vaccination certificate. Other factors driving the demand for travel vaccines include increasing awareness levels, technological advancements and increasing incidence of life-threatening infectious diseases. Looking forward, IMARC Group expects the global travel vaccines market to grow at a CAGR of 8.10% during 2021-2026.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global travel vaccines market report, along with forecasts for growth at the global, regional and country-level from 2021-2026. Our report has categorized the market based on region, composition, and disease.

Breakup by Composition:

  • Mono Vaccines
  • Combination Vaccines
  • Combination vaccines currently account for the majority of the market share as they are given to travelers in order to protect against multiple diseases.

Breakup by Disease:

  • Hepatitis A
  • DPT
  • Yellow Fever
  • Typhoid
  • Hepatitis B
  • Measles and Mumps
  • Rabies
  • Meningococcal
  • Varicella
  • Japanese Encephalitis
  • Others
  • Amongst these, hepatitis A represents the largest disease, dominating the market. It is a viral disease that can be transmitted through direct contact with an infectious person or the consumption of contaminated food and water.

Regional Insights:

  • Asia Pacific
  • North America
  • Europe
  • Middle East and Africa
  • Latin America
  • On the geographical front, North America enjoys the leading position in the market. A large number of companies in the region are introducing a superior range of travel vaccines, including a vaccine against varicella.

Competitive Landscape:

The market is concentrated in nature with the presence of a handful of manufacturers who compete in terms of prices and quality. Some of the leading players operating in the market are:

  • GlaxoSmithKline Pharmaceuticals Limited
  • Sanofi Pasteur
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • ALK-Abello A/S
  • Bavarian Nordic A/S
  • Crucell (Subsidiary of Johnson & Johnson)
  • CSL Limited
  • AstraZeneca PLC
  • Altimmune, Inc.
  • Abbott Laboratories
  • Hoffmann-La Roche, Inc.

Key Questions Answered in This Report:

  • 1. What was the global travel vaccines market size in 2020?
  • 2. What will be the travel vaccines market outlook during the forecast period (2021-2026)?
  • 3. What are the global travel vaccines market drivers?
  • 4. What are the major trends in the global travel vaccines market?
  • 5. What is the impact of COVID-19 on the global travel vaccines market?
  • 6. What is the global travel vaccines market breakup by composition?
  • 7. What is the global travel vaccines market breakup by disease?
  • 8. What are the major regions in the global travel vaccines market?
  • 9. Who are the leading travel vaccines market players?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Travel Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Composition
  • 5.5 Market Breakup by Disease
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast

6 Market Breakup by Composition

  • 6.1 Mono Vaccines
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Combination Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Disease

  • 7.1 Hepatitis A
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 DPT
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Yellow Fever
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Typhoid
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Hepatitis B
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Measles and Mumps
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Rabies
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Meningococcal
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast
  • 7.9 Varicella
    • 7.9.1 Market Trends
    • 7.9.2 Market Forecast
  • 7.10 Japanese Encephalitis
    • 7.10.1 Market Trends
    • 7.10.2 Market Forecast
  • 7.11 Others
    • 7.11.1 Market Trends
    • 7.12.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Global Travel Vaccines Industry: SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Global Travel Vaccines Industry: Value Chain Analysis

  • 10.1 Exploratory Stage
  • 10.2 Preclinical and Clinical Development
  • 10.3 Regulatory Approval
  • 10.4 Manufacturing
  • 10.5 Marketing and Distribution

11 Global Travel Vaccines Industry: Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Global Travel Vaccines Industry: Price Analysis

13 Travel Vaccines Manufacturing Process

  • 13.1 Product Overview
  • 13.2 Raw Material Requirements
  • 13.3 Manufacturing Process
  • 13.4 Key Success and Risk Factors

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 GlaxoSmithKline Pharmaceuticals Limited
    • 14.3.2 Sanofi Pasteur
    • 14.3.3 Merck & Co., Inc.
    • 14.3.4 Novartis AG
    • 14.3.5 Pfizer Inc.
    • 14.3.6 ALK-Abello A/S
    • 14.3.7 Bavarian Nordic A/S
    • 14.3.8 Crucell (Subsidiary of Johnson & Johnson)
    • 14.3.9 CSL Limited
    • 14.3.10 AstraZeneca PLC
    • 14.3.11 Altimmune, Inc.
    • 14.3.12 Abbott Laboratories
    • 14.3.13 Hoffmann-La Roche, Inc.
Back to Top
전화 문의
F A Q